REFERENCES
- Hiscott P S, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study. Br J Ophtalmol. 1984; 68: 708–715
- Clarkson J G, Green W R, Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1997; 84(1)1–17
- Machemer R, van Horn D, Aaberg T M. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978; 85: 181–191, [PUBMED], [INFOTRIEVE]
- Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol. 1990; 74: 393–399, [PUBMED], [INFOTRIEVE]
- Barile G R, Chang S, Park L S, Reppucci V S, Schiff W M, Schmidt A M. Soluble cellular adhesive molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res. 1999; 19: 219–227, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brown G C, Tasman W S, Benson W E, McNamara J A, Eagle R C, Jr. Reoperation following diabetic vitrectomy. Arch Ophthalmol. 1992; 110: 506–510, [PUBMED], [INFOTRIEVE]
- Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 1998; 21: 1759–1763, [PUBMED], [INFOTRIEVE], [CSA]
- Pray T R, Parlati F, Huang J, Wong B R, Payan D G, Bennett M K, Issakani S D, Molineaux S, Demo S D. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat. 2002; 5: 249–258, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nickoloff B J, Qin J Z, Chaturvedi V, Bacon P, Panella J, Denning M F. Life and death signaling pathways contributing to skin cancer. J Investig Dermatol Symp Proc. 2002; 7: 27–35, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kyprianou N, Isaacs J T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology. 1998; 122: 552–562, [CSA]
- Kanitakis J, Narvaez D, Euvrard S, Faure M, Claudy A. Proliferation markers Ki-67 and PCNA in cutaneous squamous cell carcinomas: Lack of prognostic value. Br J Dermatol. 1997; 136(4)643–644, [PUBMED], [INFOTRIEVE]
- Iatropoulos M J, Williams G M. Proliferation markers. Exp Toxicol Pathol. 1996; 48: 175–181, [PUBMED], [INFOTRIEVE], [CSA]
- Yu C C, Woods A L, Levison D A. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem J. 1992; 24: 121–131, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Duchrow M, Gerdes J, Schluter C. The proliferation-associated Ki-67 protein: Definition in molecular terms. Cell Prolif. 1994; 27: 235–242, [PUBMED], [INFOTRIEVE], [CSA]
- Naiem M, Gerdes J, Abdulaziz Z, Stein H, Mason D Y. Production of a mouse monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol. 1983; 36(2)167–175, [PUBMED], [INFOTRIEVE]
- Bravo R, Frank R, Blundell P A, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987; 326: 515–517, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kelman Z. PCNA: Structure, functions and interactions. Oncogene. 1997; 14: 629–640, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bethwaite P B, Delahunt B, Holloway L J, Thornton A. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma. Pathology 1995; 27: 1–4, [PUBMED], [INFOTRIEVE], [CSA]
- Heidenkummer H P, Kampik A, Petrovski B. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Retina 1992; 12: 52–58, [PUBMED], [INFOTRIEVE]
- Martinou J C, Desagher S, Antonsson B. Cytochrome c release from mitochondria: All or nothing. Nat Cell Biol. 2000; 2: E41–E43, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li H, Yuan J. Deciphering the pathways of life and death. Curr Opin Cell Biol. 1999; 11: 261–266, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kroemer G, Reed J C. Mitochondrial control of cell death. Nat Med. 2000; 6: 513–519, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Esser P, Heimann K, Bartz-Schmidt K U, Fontana A, Schraermeyer U, Thumann G, Weller M. Apoptosis in proliferative vitroretinal disorders: Possible involvement of TGF-beta induced RPE cell apoptosis. Exp Eye Res. 1997; 65: 365–378, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weller M, Heimann K, Bartz-Schmidt K U, Fontana A, Esser P. CD 95 expression in traumatic proliferative vitreoretinopathy: A target for the induction of apoptosis. Ger J Ophthalmol. 1996; 5: 332–337, [PUBMED], [INFOTRIEVE], [CSA]
- Gavrieli Y, Sherman Y, Ben-Sasson S A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119: 493–501, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ito Y, Otsuki Y. Localization of apoptotic cells in the human epidermis by an in situ DNA nick end-labeling method using confocal reflectant laser microscopy. J Histochem Cytochem. 1998; 46: 783–786, [PUBMED], [INFOTRIEVE], [CSA]
- Hinton D R, He S, Lopez P F. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol. 1998; 116: 203–209, [PUBMED], [INFOTRIEVE], [CSA]
- Gould V E, Koukoulis G K, Jansson D S, Nagle R B, Franke W W, Moll R. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am J Pathol. 1990; 137: 1143–1155, [PUBMED], [INFOTRIEVE]
- Guo Y, Sigman D B, Borkowski A, Kyprianou N. Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients. Prostate 2000; 42: 130–136, [PUBMED], [INFOTRIEVE], [CROSSREF]
- El Ghrably I, Powe D G, Orr G, Fischer D, McIntosh R, Dua H S, Tighe P J. Apoptosis in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004; 45(5)1473–1479, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mandava N, Blackburn P, Paul D B, Wilson M W, Read S B, Alspaugh E, Tritz R, Barber J R, Robbins J M, Kruse C A. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2002; 43: 3338–3348, [PUBMED], [INFOTRIEVE], [CSA]